US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist

1.730
-0.090-4.95%

Close Feb 25 16:00 ET

1.720
-0.010-0.58%

Post 19:58 ET

340.87MMarket Cap-2.58P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics Q4 2024 Estimates Date

Currency：USDMar 4, 2025

	Estimate	YoY
Revenue	61.58M	+90.96%
EPS	-0.15	+70.35%

Analyst Rating

Buy

Feb 11, 2025

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 50.641M	--
Mar 4, 2025	2024/Q4	-- / 61.584M	--
Nov 7, 2024	2024/Q3	51.632M / 51.714M	--
Aug 12, 2024	2024/Q2	73.834M / 47.500M	--
May 7, 2024	2024/Q1	137.735M / 83.888M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 50.641M--

Mar 4, 20252024/Q4-- / 61.584M--

Nov 7, 20242024/Q351.632M / 51.714M--

Aug 12, 20242024/Q273.834M / 47.500M--

May 7, 20242024/Q1137.735M / 83.888M--

Unlock Free Earnings Estimates

Open Account

Esperion Therapeutics Earnings Reports

Esperion Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:29 ET

Esperion Therapeutics | 8-K: Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 7, 2024 07:23 ET

Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 16:12 ET

Esperion Therapeutics | 8-K: Esperion Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 12, 2024 07:26 ET